Racial differences in three major NHL subtypes: Descriptive epidemiology

Cancer Epidemiology

Volumn 39, Issue 1, 2015, Pages 8-13

  Li, Yang ^a   Wang, Yu ^a   Wang, Zhuoyue ^a   Yi, Danhui ^a   Ma, Shuangge ^a,b  

^a RENMIN UNIVERSITY OF CHINA   (China)

^b YALE UNIVERSITY   (United States)

Author keywords

Non Hodgkin lymphoma; Racial differences; SEER; Subtype

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASIAN; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HISPANIC; HUMAN; INFANT; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; NONHODGKIN LYMPHOMA; PACIFIC ISLANDER; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE; SMALL LYMPHOCYTIC LYMPHOMA; YOUNG ADULT; ANCESTRY GROUP; ETHNOLOGY; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED STATES; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; INCIDENCE; INFANT; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84925146155     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.12.001     Document Type: Article

References (38)

1. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11 [Internet] 2013, International Agency for Research on Cancer, Lyon, France, Available from: http://globocan.iarc.fr [accessed December 2013].
2. National Cancer Institute, . http://www.cancer.gov/cancertopics/types/non-hodgkin.
3. Leukemia and Lymphoma Society, . http://www.lls.org/diseaseinformation/lymphoma/nonhodgkinlymphoma/nhlsubtypes/.
4. Zhang Y., Dai Y., Zheng T., Ma S. Risk factors of non-Hodgkin lymphoma. Expert Opin Med Diagn 2011, 5(November (6)):539-550.
5. Ma S. Risk factors of follicular lymphoma. Expert Opin Med Diagn 2012, 6(July (4)):323-333.
6. Dotan E., Aggarwal C., Smith M.R. Impact of Rituximab (Rituxan) on the treatment of B-cell non-Hodgkin's lymphoma. PT 2010, 35:148-157.
7. Shenoy P.J., Malik N., Nooka A., Sinha R., Ward K.C., Brawley O.W., et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer 2010, 117(11):2530-2540.
8. Griffiths R., Gleeson M., Knopf K., Danese M. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL). BMC Cancer 2010, 12(10):625.
9. Flowers C.R., Shenoy P.J., Borate U., Bumpers K., Douglas-Holland T., King N., et al. Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma 2013, 54:268-276.
10. Evens A.M., Antillón M., Aschebrook-Kilfoy B., Chiu B.C. Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis. Ann Oncol 2012, 23:2128-2137.
11. Nabhan C., Byrtek M., Taylor M.D., Friedberg J.W., Cerhan J.R., Hainsworth J.D., et al. Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study. Cancer 2012, 118:4842-4850.
12. Koshiol J., Lam T.K., Gridley G., Check D., Brown L.M., Landgren O. Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States. J Clin Oncol 2011, 29(4):378-385.
13. Kato I., Booza J., Quarshie W.O., Schwartz K. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma. J Registry Manag 2012, 39(4):158-166.
14. Morton L.M., Wang S.S., Devesa S.S., Hartge P., Weisenburger D.D., Linet M.S. Lymphoma incidence patterns by WHO subtype in the United States: 1992-2001. Blood 2006, 107(1):265-276.
15. Shenoy P.J., Malik N., Sinha R., Nooka A., Nastoupil L.J., Smith M., et al. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk 2011, 11(6):498-506.
16. Ederer F., Axtell L.M., Cutler S.J. The relative survival rate: a statistical methodology. NCI Monogr 1961, 6:101-121.
17. Marcos-Gragera R., Allemani C., Tereanu C., De Angelis R., Capocaccia R., Maynadie M., et al. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project. Haematologica 2011, 96(5):720-728.
18. Yoon S.O., Suh C., Lee D.H., Chi H.S., Park C.J., Jang S.S., et al. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification. Am J Hematol 2010, 85(10):760-764.
19. Smith A., Howell D., Patmore R., Jack A., Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 2011, 105(11):1684-1692.
20. Sader-Ghorra C., Rassy M., Naderi S., Kourie H.R., Kattan J. Type distribution of lymphomas in Lebanon: five-year single institution experience. Asian Pac J Cancer Prev 2014, 15(14):5825-5828.
21. Szumera-Ciećkiewicz A., Gałazka K., Szpor J., Rymkiewicz G., Jesionek-Kupnicka D., Gruchała A., et al. Distribution of lymphomas in Poland according to World Health Organization classification: analysis of 11718 cases from National Histopathological Lymphoma Register project - the Polish Lymphoma Research Group study. Int J Clin Exp Pathol 2014, 7(6):3280-3286.
22. Koshiol J., Lam T.K., Gridley G., Check D., Brown L.M., Landgren O. Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States. J Clin Oncol 2011, 29:378-385.
23. Smedby K.E., Hjalgrim H. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol 2011, 21:293-298.
24. Komrokji R.S., Al Ali N.H., Beg M.S., Safa M.M., Rollison D., Kharfan-Dabaja M., et al. Outcome of diffuse large B-cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data. Clin Lymphoma Myeloma Leuk 2011, 11:257-260.
25. McFall A.M., Dowdy D.W., Zelaya C.E., Murphy K., Wilson T.E., Young M.A., et al. Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. J Acquir Immune Defic Syndr 2013, 64(3):289-298.
26. Morton L.M., Hartge P., Holford T.R., Holly E.A., Chiu B.C., Vineis P., et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the international lymphoma epidemiology consortium (InterLymph). Cancer Epidemiol Biomarkers Prev 2005, 14:925-933.
27. Morton L.M., Zheng T., Holford T.R., Holly E.A., Chiu B.C., Costantini A.S., et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005, 6:469-476.
28. Zhang Y., Sanjose S.D., Bracci P.M., Morton L.M., Wang R., Brennan P., et al. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol 2008, 167:1321-1331.
29. Bachman J.G., Wallace J.M., O'Malley P.M., Johnston L.D., Kurth C.L., Neighbors H.W. Racial/ethnic differences in smoking, drinking, and illicit drug use among American high school seniors, 1976-89. Am J Public Health 1991, 81(3):372-377.
30. Substance Abuse and Mental Health Services Administration, . http://www.samhsa.gov/data/nhsda/ethnic/ethn1010.htm.
31. Chang C.M., Wang S.S., Dave B.J., Jain S., Vasef M.A., Weisenburger D.D., et al. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer 2011, 129(4):938-947.
32. Skibola C.F., Bracci P.M., Nieters A., Brooks-Wilson A., de Sanjosé S., Hughes A.M., et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 2010, 171:267-276.
33. Wong K.F., Chan J.K. Cytogenetic abnormalities in chronic B-cell lymphoproliferative disorders in Chinese patients. Cancer Genet Cytogenet 1999, 111:55-60.
34. Wang M., Burau K.D., Fang S., Wang H., Du X.L. Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer 2008, 113(11):3231-3241.
35. Pulte D., Redaniel M.T., Brenner H., Jeffreys M. Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing?. Ann Oncol 2012, 23(9):2428-2434.
36. Herd D., Grube J. Black identity and drinking in the US: a national study. Addiction 1996, 91(6):845-857.
37. Leo Q.J., Ollberding N.J., Wilkens L.R., Kolonel L.N., Henderson B.E., Le Marchand L., et al. Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort study. Cancer Causes Control 2014, [Epub ahead of print].
38. Clarke C.A., Undurraga D.M., Harasty P.J., Glaser S.L., Morton L.M., Holly E.A. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 2006, 15:630-638.